Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregor Vlacic

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Archives of Pathology & Laboratory Medicine|March 7, 2018
Reproducibility of Malignant Pleural Mesothelioma Histopathologic SubtypingLuka Brcic, Gregor Vlacic, Franz Quehenberger, et al.
Archives of Pathology & Laboratory Medicine|November 9, 2018
In ReplyLuka Brcic, Gregor Vlacic, Franz Quehenberger, et al.
Radiology and Oncology|July 26, 2017
Insulin-like Growth Factor 1 Receptor Expression in Advanced Non-small-cell Lung Cancer and its Impact on Overall SurvivalMojca Humar, Izidor Kern, Gregor Vlacic, et al.
Frontiers in Oncology|April 8, 2021
P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune MicroenvironmentFederica Pezzuto, Francesca Lunardi, Luca Vedovelli, et al.
Cells|September 19, 2019
Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor SensitivityGregor Vlacic, Mir A Hoda, Thomas Klikovits, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Archives of Pathology & Laboratory Medicine|March 7, 2018
Reproducibility of Malignant Pleural Mesothelioma Histopathologic SubtypingLuka Brcic, Gregor Vlacic, Franz Quehenberger, et al.
Archives of Pathology & Laboratory Medicine|November 9, 2018
In ReplyLuka Brcic, Gregor Vlacic, Franz Quehenberger, et al.
Radiology and Oncology|July 26, 2017
Insulin-like Growth Factor 1 Receptor Expression in Advanced Non-small-cell Lung Cancer and its Impact on Overall SurvivalMojca Humar, Izidor Kern, Gregor Vlacic, et al.
Frontiers in Oncology|April 8, 2021
P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune MicroenvironmentFederica Pezzuto, Francesca Lunardi, Luca Vedovelli, et al.
Cells|September 19, 2019
Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor SensitivityGregor Vlacic, Mir A Hoda, Thomas Klikovits, et al.
Pageof 1